Maruszewska-Cheruiyot M, Donskow-Łysoniewska K, Doligalska M
Department of Parasitology, Faculty of Biology University of Warsaw, Miecznikowa 1, 02-096 Warsaw, Poland.
Helminthologia. 2018 Jan 27;55(1):1-11. doi: 10.1515/helm-2017-0048. eCollection 2018 Mar.
Development of modern medicine and better living conditions in the 20th century helped in reducing a number of cases of infectious diseases. During the same time, expansion of autoimmunological disorders was noticed. Among other are Inflammatory Bowel Diseases (IBD) including ulcerative colitis and Crohn's disease which are chronic and relapsing inflammation of the gastrointestinal tract. Absence of effective treatment in standard therapies effects the search for alternative opportunities. As per hygienic hypothesis increasing number of cases of autoimmune diseases is as a result of reduced exposure to pathogens, especially parasites. Thus, one of the promising remedial acts against IBD and other allergic and autoimmune disorders is "helminth therapy". Cure with helminths seems to be the most effective therapy of IBD currently proposed. Helminth therapy focuses on advantageous results that have been obtained from the clinical trials, but its mechanisms are still unclear. Explanation of this phenomenon would help to develop new drugs against IBD based on helminth immunomodulatory molecules.
20世纪现代医学的发展和生活条件的改善有助于减少传染病的病例数量。与此同时,自身免疫性疾病的范围却在扩大。其中包括炎症性肠病(IBD),如溃疡性结肠炎和克罗恩病,它们是胃肠道的慢性复发性炎症。标准疗法中缺乏有效的治疗方法促使人们寻找替代方案。根据卫生假说,自身免疫性疾病病例数量的增加是由于接触病原体,尤其是寄生虫的机会减少所致。因此,针对炎症性肠病以及其他过敏和自身免疫性疾病,一种有前景的治疗方法是“蠕虫疗法”。用蠕虫进行治疗似乎是目前所提出的治疗炎症性肠病最有效的方法。蠕虫疗法关注的是从临床试验中获得的有益结果,但其机制仍不清楚。对这一现象的解释将有助于开发基于蠕虫免疫调节分子的治疗炎症性肠病的新药。